SYM Financial Corp’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$569K Buy
3,992
+8
+0.2% +$1.21K 0.04% 144
2026
Q2
$624K Buy
3,984
+450
+13% +$67.5K 0.05% 115
2026
Q1
$540K Buy
3,534
+544
+18% +$83.4K 0.05% 120
2025
Q4
$412K Buy
2,990
+149
+5% +$19.5K 0.04% 158
2025
Q3
$364K Sell
2,841
-556
-16% -$67.8K 0.04% 163
2025
Q2
$411K Buy
+3,397
New +$383K 0.05% 153
2024
Q4
– Sell
-1,835
Closed -$211K – 351
2024
Q3
$211K Buy
+1,835
New +$208K 0.03% 169

Other funds holding NVS

SYM Financial Corp's NVS Position: Q3 2026 in Review

SYM Financial Corp increased its Novartis (NVS) stake by 0.2% in Q3 2026, buying an estimated $1.21K and bringing the position to 3,992 shares worth $569K. The position accounts for 0.04% of the portfolio, ranked #144.

SYM Financial Corp first reported a position in NVS in Q3 2024 and has held it in 7 quarters since. The position peaked at $624K in Q2 2026. 939 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • SYM Financial Corp held 3,992 shares of Novartis worth $569K as of Q3 2026.
  • SYM Financial Corp bought 8 Novartis shares in Q3 2026, an estimated $1.21K.
  • Novartis made up 0.04% of SYM Financial Corp's portfolio in Q3 2026, its #144 holding.
  • SYM Financial Corp first reported a position in Novartis in Q3 2024 and has held it in 7 quarters since.
  • SYM Financial Corp's Novartis position peaked at $624K in Q2 2026.
  • 939 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on SYM Financial Corp's 13F filing for Q3 2026, filed 26 Oct 2026.